Table I.
Groups | Itraconazole, n=22 | Control, n=38 |
---|---|---|
Median age (range) | 53 (43–71) | 56 (39–73) |
Women, n (%) | 6 (27.2) | 12 (31.6) |
Men, n (%) | 16 (72.8) | 26 (68.4) |
ECOG PS, n (%) | ||
0 | 2 (9.0) | 3 (7.9) |
1 | 17 (77.3) | 30 (79) |
2 | 3 (13.6) | 5 (13.1) |
Metastasis positive, n (%) | 4 (18.2) | 8 (21.1) |
Histological type, n (%) | ||
Adenocarcinoma | 22 (100.0) | 37 (97.3) |
Other | 0 (0.0) | 1 (2.7) |
ECOG, Eastern Cooperative Oncology Group; PS, performance status.